This website needs JavaScript to work properly. Please activate JavaScript on your browser.
Menu
Research
Pioneering a Future Without Crohn’s Disease
Project Structure
Sister Projects
About Crohn's Disease
What is Crohn’s disease?
Current Treatment Options: A persistent gap
INTERCEPT: Shifting from late diagnosis to early(er) detection and prevention
Preclinical phase of Crohn’s disease – A new window of opportunity
The study
Partners
Events & News
Contact us
Partners
LinkedIn
Facebook
Austria
United European Gastroenterology GmbH
Belgium
European Federation of Crohn's and Ulcerative Colitis Associations
Denmark
Aalborg Universitet
France
Centre Hospitalier Universitaire de Lille
Germany
European Research and Project Office GmbH
Italy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Gemelli Digital Medicine & Health srl
Netherlands
Stichting Amsterdam UMC
Stichting VU
Richard Vesely
University Medical Center Groningen
Norway
Norges Teknisk-Naturvitenskapelige Universitet
Poland
National Medical Institute of the Ministry of the Interior and Administration
Portugal
GLSMED Learning Health SA/Hospital da Luz
South Korea
Celltrion Inc
Spain
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa Gettecu
Sweden
Örebro University
Switzerland
Takeda Pharmaceutical Company Limited
United Kingdom of Great Britain
The Chancellor, Masters and Scholars of the University of Oxford
Ludger Limited
United States of America
Icahn School of Medicine at Mount Sinai
Prometheus Laboratories Inc